Enact Trial - Enza vs Active Surveillance in Localized Prostate Cancer

What happens when you treat people with $168,000 a year medicine when most of them will never need treatment, and all of them don't need treatment now

Om Podcasten

A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California, San Francisco. Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com.